The startup develops cell-free biosensing products that utilize genetically encoded sense and response mechanisms for chemical and molecular testing. This technology enables accurate and scalable detection of chemicals, providing medical professionals with faster test results at lower costs.
Funding
$260K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional chemical and molecular testing methods often rely on analytical instrumentation or antibody-based assays, which can be expensive, require specialized equipment and trained operators, and may not be easily scalable or adaptable to diverse chemistries. This can lead to delays in obtaining critical chemical data and limit the ability to perform frequent, on-site testing.
Solution
Stemloop provides a biosensor platform, ROSALIND™, that enables direct and accurate testing of a wide range of chemical analytes. Unlike traditional methods, Stemloop's cell-free biosensors utilize genetically encoded sense and response mechanisms to detect small molecules, ranging from 20 to 2,000 Daltons, across diverse chemistries, including functional groups and chiral centers. The biosensors are designed for rapid, on-site testing, providing results in minutes without the need for specialized equipment or extensive training. This allows for more frequent and accessible chemical data, enabling informed action and improved process control.
Target Audience
Stemloop's primary customers include professionals in industries such as environmental monitoring, manufacturing, and healthcare, who require rapid, accurate, and scalable chemical testing solutions.
Features
- ROSALIND™ platform for direct and accurate detection of small molecules
- Cell-free biosensors utilizing genetically encoded sense and response mechanisms
- Detection of a wide range of chemical analytes from 20 to 2,000 Daltons
- Ability to detect diverse chemistries, including functional groups and chiral centers
- Rapid, on-site testing with results in minutes
- No specialized equipment or extensive training required
- Tunable parameters for custom-built biosensors
- Lower limit of detection than analytical chemistry